High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer

Show full item record



Permalink

http://hdl.handle.net/10138/315068

Citation

Carpen , T , Sorsa , T , Jouhi , L , Tervahartiala , T , Haglund , C , Syrjänen , S , Tarkkanen , J , Mohamed , H , Mäkitie , A , Hagström , J & Mattila , P S 2019 , ' High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer ' , Cancer Immunology, Immunotherapy , vol. 68 , no. 8 , pp. 1263-1272 . https://doi.org/10.1007/s00262-019-02362-4

Title: High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer
Author: Carpen, Timo; Sorsa, Timo; Jouhi, Lauri; Tervahartiala, Taina; Haglund, Caj; Syrjänen, Stina; Tarkkanen, Jussi; Mohamed, Hesham; Mäkitie, Antti; Hagström, Jaana; Mattila, Petri S.
Contributor: University of Helsinki, Department of Ophthalmology and Otorhinolaryngology
University of Helsinki, HUS Head and Neck Center
University of Helsinki, HUS Head and Neck Center
University of Helsinki, HUS Head and Neck Center
University of Helsinki, HUS Abdominal Center
University of Helsinki, Department of Pathology
University of Helsinki, Department of Pathology
University of Helsinki, HUS Head and Neck Center
University of Helsinki, HUS Head and Neck Center
University of Helsinki, HUS Head and Neck Center
Date: 2019-08
Language: eng
Number of pages: 10
Belongs to series: Cancer Immunology, Immunotherapy
ISSN: 0340-7004
URI: http://hdl.handle.net/10138/315068
Abstract: Background An emerging subset of oropharyngeal squamous cell carcinomas (OPSCC) is caused by HPV. HPV-positive OPSCC has a better prognosis than HPV-negative OPSCC, but other prognostic markers for these two different diseases are scarce. Our aim was to evaluate serum levels and tumor expression of matrix metalloproteinase-8 (MMP-8) and tissue inhibitor of metalloproteinase-1 (TIMP-1) and to assess their prognostic role in HPV-positive and HPV-negative OPSCC. Materials and methods A total of 90 consecutive OPSCC patients diagnosed and treated with curative intent at the Helsinki University Hospital between 2012 and 2016 were included. Serum samples were prospectively collected. An immunofluorometric assay and an enzyme-linked immunosorbent assay were used to determine MMP-8 and TIMP-1 serum concentrations, respectively. HPV status of the tumors was determined using a combination of HPV-DNA genotyping and p16-INK4a immunohistochemistry. The endpoints were overall survival (OS) and disease-free survival (DFS). Results High TIMP-1 serum levels were strongly and independently associated with poorer OS (adjusted HR 14.7, 95% CI 1.8-117.4, p = 0.011) and DFS (adjusted HR 8.7, 95% CI 1.3-57.1, p = 0.024) among HPV-negative patients; this association was not observed in HPV-positive OPSCC. Although TIMP-1 was immunoexpressed in the majority of the tumor tissue samples, the level of immunoexpression was not associated with prognosis, nor did MMP-8 serum levels. Conclusion Our results indicate that serum TIMP-1 levels may serve as an independent prognostic marker for HPV-negative OPSCC patients.
Subject: HPV
Oropharyngeal cancer
MMP-8
TIMP-1
Survival
Prognosis
HUMAN-PAPILLOMAVIRUS
MATRIX METALLOPROTEINASE-8
COLLAGENASE-2 MMP-8
GROWTH-FACTOR
NECK-CANCER
HEAD
CARCINOMA
EXPRESSION
SURVIVAL
MATRIX-METALLOPROTEINASE-9
3122 Cancers
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Carp_n_et_al_20 ... munology_Immunotherapy.pdf 1006.Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record